HHS Assails Eli Lilly's Bid To Halt Drug Discount Rule

By Adam Lidgett · February 17, 2021, 7:57 PM EST

The U.S. Department of Health and Human Services has shot back at Eli Lilly and Co.'s attempt to block the agency from deciding what discounts the drugmaker owes pharmacies that contract...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Response

Case Information

Case Title

ELI LILLY AND COMPANY et al v. HEALTH RESOURCES AND SERVICES ADMINISTRATION, et al

Case Number

1:21-cv-00081

Court

Indiana Southern

Nature of Suit

899(Other Statutes: Administrative Procedures Act/Review or Appeal of Agency Decision)

Date Filed

January 12, 2021

Recent Articles By Adam

June 03, 2025
Patent Deals Accelerate Access To Generics, Drug Group Says
April 11, 2025
Foreign Cos. Say Anti-Choking Device Patent Is Invalid
April 11, 2025
Aurinia Sues Lotus Alleging Lupus Drug Patent Infringement
April 08, 2025
Pacira Reaches IP Deal Allowing Generic Painkiller In 2030
April 07, 2025
Incyte Can't Get Pretrial Win In Novartis Royalty Fight
April 03, 2025
Texas Appeals Court Backs UT Royalty Award In Pet Co. Suit
March 27, 2025
Fitch Even Sues Ex-IP Client In Effort To End Malpractice Case
March 24, 2025
Amgen Wants $50M Leukemia Drug Patent Verdict Thrown Out
March 18, 2025
Bausch Eye Vitamin Case Should Go To Jury, Judge Says
March 18, 2025
AI Healthcare Co. Accuses Test-Maker Of Infringing Patents